万泽股份涨2.01%，成交额1.93亿元，主力资金净流入291.12万元

Group 1 - The core viewpoint of the news is that Wanze Co., Ltd. has shown significant stock performance with a year-to-date increase of 78.20%, despite a recent decline of 7.56% over the last five trading days [1] - As of December 22, Wanze's stock price reached 22.85 yuan per share, with a total market capitalization of 11.643 billion yuan [1] - The company has a diverse revenue structure, with its main business segments being: Jinshuangqi (48.91%), high-temperature alloy materials (26.30%), and Dingjunsheng (23.12%) [1] Group 2 - Wanze Co., Ltd. operates in the pharmaceutical and biological industry, specifically in the bioproducts sector, and is involved in various concept sectors including gas turbines and aerospace [2] - For the period from January to September 2025, Wanze reported a revenue of 941 million yuan, reflecting a year-on-year growth of 21.00%, and a net profit attributable to shareholders of 170 million yuan, up by 22.45% [2] - The company has distributed a total of 645 million yuan in dividends since its A-share listing, with 107 million yuan distributed over the past three years [3]